Acta Vet. Brno 2007, 76: 613-618

https://doi.org/10.2754/avb200776040613

Etoricoxib in the Prevention of Rat Mammary Carcinogenesis

P. Orendáš1, I. Ahlers1, P. Kubatka2, E. Ahlersová1, B. Bojková1, M. Kassayová1, L. Friedmanová1, J. Kisková1, I. Ďatelinka1, M. Starostová1

1Department of Animal Physiology, Institute of Biological and Ecological Sciences, Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
2Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovak Republic

Received July 27, 2006
Accepted October 2, 2007

Crossref Cited-by Linking

  • Singh Madhu Tanya, Thaggikuppe Krishnamurthy Praveen, Magham Sai Varshini: Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells. Journal of Drug Targeting 2024, 32, 258. <https://doi.org/10.1080/1061186X.2024.2309568>
  • El-Malah Afaf A., Gineinah Magdy M., Deb Pran Kishore, Khayyat Ahdab N., Bansal Monika, Venugopala Katharigatta N., Aljahdali Anfal S.: Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing. Pharmaceuticals 2022, 15, 827. <https://doi.org/10.3390/ph15070827>
  • Orendáš Peter, Ahlers Ivan, Bojková Bianka, Kassayová Monika, Kubatka Peter, Kajo Karol, Péč Martin, Ahlersová Eva, Friedmanová Lenka: Chemopreventive effect of diclofenac on mammary carcinogenesis in Sprague-Dawley rats. Biologia 2013, 68, 733. <https://doi.org/10.2478/s11756-013-0205-3>
Crossref Cited-by Linking logo